biospecimen_aliquot__bcr_aliquot_barcode	tcga-e9-a22d-01a-11d-a159-09
biospecimen_aliquot__bcr_aliquot_uuid	3dfdc7fd-3f69-4297-a4cf-1a05b75d302f
biospecimen_aliquot__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
biospecimen_aliquot__bcr_sample_barcode	tcga-e9-a22d-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099054635
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-05-17
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	4
biospecimen_aliquot__plate_id	a159
biospecimen_aliquot__plate_row	c
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.22
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e9-a22d-01a-11d
biospecimen_analyte__bcr_analyte_uuid	fd87e1cf-2c92-46b9-b568-996b40d29916
biospecimen_analyte__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
biospecimen_analyte__bcr_sample_barcode	tcga-e9-a22d-01a
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e9-a22d
biospecimen_diagnostic_slides__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e9-a22d-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	b2867437-0add-4b7d-8002-fb09ed961942
biospecimen_normal_control__bcr_patient_barcode	tcga-e9-a22d
biospecimen_normal_control__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
biospecimen_portion__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
biospecimen_portion__bcr_portion_barcode	tcga-e9-a22d-01a-11
biospecimen_portion__bcr_portion_uuid	b8e48575-7d6d-49e8-888a-3468a6707986
biospecimen_portion__bcr_sample_barcode	tcga-e9-a22d-01a
biospecimen_portion__date_of_creation	2011-04-11
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e9-a22d-01a-11d
biospecimen_protocol__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
biospecimen_protocol__bcr_sample_barcode	tcga-e9-a22d-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
biospecimen_sample__bcr_sample_barcode	tcga-e9-a22d-01a
biospecimen_sample__bcr_sample_uuid	0d7c1a37-5da1-4257-a118-b7d0717f23da
biospecimen_sample__days_to_collection	52
biospecimen_sample__initial_weight	620
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-e9-a22d.ed60f792-a71b-4bae-a536-5ff6d8c3deaa.pdf
biospecimen_sample__pathology_report_uuid	ed60f792-a71b-4bae-a536-5ff6d8c3deaa
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e9-a22d-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	4691c2b1-8da2-48b4-9510-badea3a8353f
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17k
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e9-a22d-01a-21-a17k-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
biospecimen_slide__bcr_sample_barcode	tcga-e9-a22d-01a
biospecimen_slide__bcr_slide_barcode	tcga-e9-a22d-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	1d806ebb-4c31-45ae-898e-139903e04c43
biospecimen_slide__image_file_name	tcga-e9-a22d-01a-01-tsa.1d806ebb-4c31-45ae-898e-139903e04c43.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	5
biospecimen_slide__percent_tumor_cells	95
biospecimen_slide__percent_tumor_nuclei	85
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e9-a22d
biospecimen_tumor_sample__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
clinical_drug__bcr_drug_barcode	tcga-e9-a22d-d29927
clinical_drug__bcr_drug_uuid	19d3b016-37b3-4cd9-8ead-68e4ae3a15c4
clinical_drug__bcr_patient_barcode	tcga-e9-a22d
clinical_drug__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
clinical_drug__form_completion_date	2012-3-30
clinical_drug__pharma_adjuvant_cycles_count	6
clinical_drug__pharmaceutical_therapy_drug_name	cyclophosphane
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ended_days_to	189
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	16
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	900
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	3600
clinical_follow_up__bcr_followup_barcode	tcga-e9-a22d-f29912
clinical_follow_up__bcr_followup_uuid	e2bbdab7-ac72-4f40-b2cf-8892d5b09cd1
clinical_follow_up__bcr_patient_barcode	tcga-e9-a22d
clinical_follow_up__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2013-11-27
clinical_follow_up__last_contact_days_to	402
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	38
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	right upper outer quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-e9-a22d
clinical_patient__bcr_patient_uuid	cf0a3f38-5850-44e1-8574-808bd37d84a3
clinical_patient__birth_days_to	-14115
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	10-19%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-8-2
clinical_patient__gender	female
clinical_patient__her2_ihc_percent_positive	<10%
clinical_patient__her2_status_by_ihc	positive
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2011
clinical_patient__last_contact_days_to	0
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	10
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a22d
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	e9
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E9-A22D-01A-11D-A159-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E9-A22D-01A-11D-A159-09.bed.meta
manually_curated__id	tcga-e9-a22d-01a-11d-a159-09
manually_curated__md5sum	7f54610efbc71d06f4ee5827c47db556
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	3dfdc7fd-3f69-4297-a4cf-1a05b75d302f
manually_curated__tumor_tag	brca
